MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Cash and cashequivalents$189,163K Prepaid expenses andother current assets$6,400K Total current assets$195,563K Operating leaseright-of-use assets$1,372K Other assets$1,159K Property and equipment,net$929K Restricted cash$107K Total assets$199,130K Total liabilities,convertible preferred...$199,130K Total shareholders'equity$183,847K Total liabilities$15,283K Accumulated deficit-$195,092K Additional paid-in capital$374,911K Total currentliabilities$14,193K Operating leaseliability, noncurrent$1,090K Non-voting convertiblepreferred shares, 0.001...$4,000K Ordinary shares, 0.001par value...$28K Deposit liability$5,000K Accrued expenses andother current...$4,433K Deferred revenue$3,117K Accountspayable-Nonrelated Party$1,190K Operating leaseliability, current$453K
Balance Sheet

CRESCENT BIOPHARMA, INC. (CBIO)

CRESCENT BIOPHARMA, INC. (CBIO)

source: myfinsight.com